Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Change in Cash (2016 - 2025)

Bio-Techne (TECH) has 17 years of Change in Cash data on record, last reported at $27.9 million in Q4 2025.

  • For Q4 2025, Change in Cash rose 379.42% year-over-year to $27.9 million; the TTM value through Dec 2025 reached -$4.7 million, down 109.85%, while the annual FY2025 figure was $10.4 million, 136.12% up from the prior year.
  • Change in Cash reached $27.9 million in Q4 2025 per TECH's latest filing, up from -$17.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $53.3 million in Q2 2023 and bottomed at -$51.0 million in Q1 2022.
  • Average Change in Cash over 5 years is $367650.0, with a median of $4.6 million recorded in 2022.
  • Peak YoY movement for Change in Cash: skyrocketed 500.31% in 2021, then crashed 3122.78% in 2023.
  • A 5-year view of Change in Cash shows it stood at $15.5 million in 2021, then tumbled by 103.7% to -$575000.0 in 2022, then plummeted by 3122.78% to -$18.5 million in 2023, then skyrocketed by 46.08% to -$10.0 million in 2024, then surged by 379.42% to $27.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $27.9 million in Q4 2025, -$17.2 million in Q3 2025, and $21.5 million in Q2 2025.